Methods for producing paper or cardboard are provided that comprise the steps (A) adding a final polymer A to a first aqueous fibrous material suspension, whereby a second aqueous fibrous material suspension containing final polymer A is created, wherein the final polymer A is obtainable by radical polymerisation of the monomers (i), (ii), (iii), (iv), and (v) as described herein in the amounts provided herein; and hydrolysing the starting polymer V in order to obtain the final polymer A, (B) dewatering the second aqueous fibrous material suspension containing final polymer A on a water-permeable substrate to form a wet paper structure, (C) dewatering the wet paper structure, whereby the paper or the cardboard is formed.

Coating compositions are provided. In embodiments, a coating composition comprises a solvent system comprising water; a crosslinked organic additive in the form of particles and comprising a polymerization product of reactants comprising a multifunctional vinyl monomer comprising two or more vinyl groups; a binder; and optionally, one or more of a colorant and a wax. Methods of making and using the coating compositions are also provided.

Coating compositions are provided. In embodiments, a coating composition comprises a solvent system comprising water; a crosslinked organic additive in the form of particles and comprising a polymerization product of reactants comprising a multifunctional vinyl monomer comprising two or more vinyl groups; a binder; and optionally, one or more of a colorant and a wax. Methods of making and using the coating compositions are also provided.

The present application provides a binder and a lithium-ion battery including the binder. The binder is rich in amino groups, has strong alkali resistance and is not easy to decompose. Besides, rich amino groups in the binder are prone to form hydrogen bonds, so that the binder more fully coats an active material and can enhance an acting force between the active material and a current collector, improve a peeling strength of an electrode piece, and significantly improve a cycling performance, expansion rate, and rate capability of lithium-ion batteries using the binder.

The present application provides a binder and a lithium-ion battery including the binder. The binder is rich in amino groups, has strong alkali resistance and is not easy to decompose. Besides, rich amino groups in the binder are prone to form hydrogen bonds, so that the binder more fully coats an active material and can enhance an acting force between the active material and a current collector, improve a peeling strength of an electrode piece, and significantly improve a cycling performance, expansion rate, and rate capability of lithium-ion batteries using the binder.

Copolymer compositions and methods of making copolymer compositions with enhanced stability in high temperature and high salinity environments. The copolymers include hydrophobic monomers and sulfonated monomers. The sulfonated monomers can include 2-acrylamido-2-methylpropane sulfonic acid and allyl sulfonate. The sulfonated monomers increase the stability of the polymers in harsh conditions, and in high temperature, high salinity environments. The sulfonated monomers also reduce or prevent the hydrolysis of acrylamide groups, and therefore enhance the stability of the copolymer. The copolymer compositions can be made with free radical polymerization and an initiation complex.

Copolymer compositions and methods of making copolymer compositions with enhanced stability in high temperature and high salinity environments. The copolymers include hydrophobic monomers and sulfonated monomers. The sulfonated monomers can include 2-acrylamido-2-methylpropane sulfonic acid and allyl sulfonate. The sulfonated monomers increase the stability of the polymers in harsh conditions, and in high temperature, high salinity environments. The sulfonated monomers also reduce or prevent the hydrolysis of acrylamide groups, and therefore enhance the stability of the copolymer. The copolymer compositions can be made with free radical polymerization and an initiation complex.

Disclosed herein are methods for synthesizing oligomer mixtures with one or more moieties capable of forming a multi-hydrogen bonding dimer. The method comprises the steps of providing certain intermediate reaction products; adding a polyol component to the intermediate reaction product to yield an oligomer mixture comprising one or more multi-hydrogen bonding groups; and further reacting the mixture with certain isocyanate-reactive compounds to yield a multi-hydrogen bonding oligomer, wherein solvents comprise less than 50% of the total by weight of all reagents used in the synthesis of the multi-hydrogen bonding oligomer. Preferably, such methods involve no separation, distillation, or isolation of any intermediate product, and as such, they are particularly useful for a continuous or one-pot synthesis.

Disclosed herein are methods for synthesizing oligomer mixtures with one or more moieties capable of forming a multi-hydrogen bonding dimer. The method comprises the steps of providing certain intermediate reaction products; adding a polyol component to the intermediate reaction product to yield an oligomer mixture comprising one or more multi-hydrogen bonding groups; and further reacting the mixture with certain isocyanate-reactive compounds to yield a multi-hydrogen bonding oligomer, wherein solvents comprise less than 50% of the total by weight of all reagents used in the synthesis of the multi-hydrogen bonding oligomer. Preferably, such methods involve no separation, distillation, or isolation of any intermediate product, and as such, they are particularly useful for a continuous or one-pot synthesis.

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.